Tradestie Institutional Equity Comparison Engine

CASI vs AADR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CASI Overall Edge

CASI Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) driven by superior Growth & Margin while AADR counters with relative strength in Momentum & Technical. Fundamentally, CASI trades at N/M Forward P/E with -333.1% operating margin (-60.5% YoY revenue) versus AADR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CASI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AADR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CASI N/M vs AADR N/M Fwd P/E
Growth & Margin Winner CASI
Op Margin -333.1% vs N/A ยท YoY -60.5% vs N/A
Momentum & Technical Winner AADR
1Y -91.4% vs -14.2% ยท 52W Pos 0% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CASI NASDAQ
CASI Pharmaceuticals, Inc. Ordinary Shares
Pharmaceutical Preparations
$0.21
-74.06% 1D
Market Cap $12.4M
1M Return -78.83%
1Y Return -91.43%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 40.0 Fund 44.0 Flow 50.0 Mom 44.0
AADR NASDAQ
AdvisorShares Dorsey Wright ADR ETF
Institutional Equity
$71.35
-3.47% 1D
Market Cap N/A
1M Return -10.26%
1Y Return -14.18%
Forward P/E N/M
Unified AI Score
39.4 / 100 SELL
Tech 15.0 Fund 46.0 Flow 50.0 Mom 69.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CASI -91.43% AADR -14.18% Spread: +96.8 pp (AADR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CASI TTM Op. Margin: -333.1% AADR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CASI vs AADR. Trailing 12-month operating profitability (CASI -333.1% vs AADR N/A) and valuation multiples (CASI N/M vs AADR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CASI (6) vs AADR (1)
Institutional Metric CASI AADR Criterion Row Winner
Market Capitalization Scale $12.4M N/A Larger Scale CASI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -60.5% N/A Higher Growth CASI
Operating Margin (TTM) Profitability -333.1% N/A Higher Margin CASI
Net Profit Margin Profitability -184.0% N/A Higher Margin CASI
Return on Equity (ROE) Capital Efficiency -1094.5% N/A Higher ROE CASI
52-Week Range Position Momentum 0% ($0โ€“$3) 0% ($71โ€“$98) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.95ฮฒ ยท 240% Vol 1.09ฮฒ ยท 25% Vol Lower Realized Risk AADR
Unified Institutional Score Composite Signal 44.7 / 100 (HOLD) 39.4 / 100 (SELL) Higher Composite CASI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CASI vs AADR Buy Guide
CASI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CASI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AADR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AADR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CASI nor AADR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.